Search
Now showing items 1-7 of 7
Myo-inositol oxygenese activity in second trimester of pregnancy: altered myoinositol catabolism in gestational diabetes mellitus
(Taylor & Francis Ltd, 2020)
Objective: We aimed to determine myo-inositol oxygenase (MIOX) activity in gestational diabetes mellitus (GDM). Material and Methods: The insulin, HbA1c, and MIOX levels of 80 pregnant women were analysed after 75 g OGTT. ...
Pro-Gastrin releasing peptide: a new serum marker for endometrioid adenocarcinoma
(Karger, 2018)
Background: Gastrin-releasing peptide (GRP) is thought to play a role in the metastatic process of various malignancies. The more stable precursor of GRP, pro-GRP (ProGRP), has been shown to be secreted by neuroendocrine ...
The impact of nuchal cord on umbilical cord blood gas analysis and ischaemia-modified albumin levels in elective C-section
(2018)
This study was designed to evaluate umbilical cord ischaemia-modified albumin (IMA) levels and the
cord blood gas parameters of foetuses with or without nuchal cords, at the time of elective C-section.
The cross-sectional ...
Maternal serum advanced glycation end products level as an early marker for predicting preterm labor/PPROM: a prospective preliminary study
(2018)
Objective: To evaluate the value of maternal serum advanced glycation end products (AGEs)
level at 11–13 weeks’ gestation for the prediction of preterm labor and or preterm premature
rupture of membranes (PPROM).
Materials ...
The levels of matrix metalloproteinase-9 and neutrophil gelatinase-associated lipocalin in different stages of endometriosis
(2019)
This study was designed to explore matrix metalloproteinase-9 (MMP-9), neutrophil gelatinase-associated
lipocalin (NGAL) levels and MMP-9/NGAL ratio in women with and without endometriosis diagnosed
surgically and/or ...
The association between ischemia modified albumin and placental histopathology in uncomplicated term deliveries
(2015)
Ischemia modified albumin (IMA) is a marker of ischemia elevated in different clinical conditions and its
use for hypoxia in perinatology is of current interest. We aimed to investigate the association between
maternal ...
CRP at early follicular phase of menstrual cycle can cause misinterpretation for cardiovascular risk assessment
(2015)
Objective: C-reactive protein (CRP) is a well-known marker of infl ammation and infection in clinical practice. This study is designed
to evaluate CRP levels in diff erent phases of menstrual cycle, which might end up ...